Jukka-Pekka Ojala

Serum ubiquinone concentrations after short- and long-term treatment with HMG-CoA reductase inhibitors

Reijo Laaksonen, Jukka-Pekka Ojala, Matti J. Tikkanen et al. · European Journal of Clinical Pharmacology · 1994 · 94 citations

Medicine, Biochemistry, Pharmacology +5

Effect of apolipoprotein E polymorphism and Xbal polymorphism of apolipoprotein B on response to lovastatin treatment in familial and non‐familial hypercholesterolaemia

Jukka-Pekka Ojala, Eero Helve, Christian Ehnholm et al. · Journal of Internal Medicine · 1991 · 72 citations

Life Sciences, Genetics, Pharmacology +16

Heterozygous familial hypercholesterolaemia: the influence of the mutation type of the low‐density‐lipoprotein receptor gene and <i>Pvu</i>II polymorphism of the normal allele on serum lipid levels and response to lovastatin treatment

A. F. VUORIO, Jukka-Pekka Ojala, Seppo Sarna et al. · Journal of Internal Medicine · 1995 · 42 citations

Life Sciences, Genetics, Molecular Genetics +17

Inhibition of Dietary Cholesterol Absorption During Lovastatin (Mevinolin) Treatment

T.A. Miettinen, Matti J. Tikkanen, Eero Helve et al. · Clinical Drug Investigation · 1990 · 20 citations

Life Sciences, Nutritional Sciences, Pharmacology +12

Treatment of Combined Hyperlipidemia with Lovastatin versus Gemfibrozil: A Comparison Study

Jukka-Pekka Ojala, Eero Helve, Matti J. Tikkanen · Cardiology · 2008 · 16 citations

Medicine, Pharmacology, Pharmacotherapy +17